Earth Science Tech (ETST) Liabilities and Shareholders Equity (2012 - 2026)

Earth Science Tech (ETST) posted Liabilities and Shareholders Equity of $9.0 million for Q1 2026, up 10.88% on a QoQ basis from $8.1 million in Q4 2025, and up 26.92% year-over-year from $7.1 million in Q1 2025.

Earth Science Tech (ETST) Liabilities and Shareholders Equity (2012 - 2026) Analysis & Trends

Earth Science Tech's Liabilities and Shareholders Equity history runs 13 years deep, the most recent figure standing at $9.0 million for Q1 2026.

  • Quarterly Liabilities and Shareholders Equity rose 26.92% year-over-year to $9.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $33.5 million (up 48.28% YoY) and the FY2026 annual result came in at $9.0 million, up 26.92% from the prior year.
  • Liabilities and Shareholders Equity was $9.0 million for Q1 2026 at Earth Science Tech, up from $8.1 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $9.0 million in Q1 2026 and bottomed at $76942.0 in Q1 2022.
  • A 5-year average of $4.3 million and a median of $3.9 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
  • Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity gained 19.17% — and 2023, when it soared 3445.49%.
  • Earth Science Tech's Liabilities and Shareholders Equity stood at $537376.0 in 2022, then soared by 511.1% to $3.3 million in 2023, then surged by 73.82% to $5.7 million in 2024, then surged by 41.72% to $8.1 million in 2025, then climbed by 10.88% to $9.0 million in 2026.
  • Business Quant data shows ETST's Liabilities and Shareholders Equity at $9.0 million in Q1 2026, $8.1 million in Q4 2025, and $8.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 43.40 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 40.04 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 15.15 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 98.91 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 6.71 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 69.30 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 36.83 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 4.91 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 13.22 Bn
10 Earth Science Tech 41.03 Mn 38.90 Mn 6.27 Mn 8.97 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 8.97 Mn
Dec 31, 2025 8.09 Mn
Sep 30, 2025 8.67 Mn
Jun 30, 2025 7.78 Mn
Mar 31, 2025 7.07 Mn
Dec 31, 2024 5.71 Mn
Sep 30, 2024 5.05 Mn
Jun 30, 2024 4.77 Mn
Mar 31, 2024 3.88 Mn
Dec 31, 2023 3.28 Mn
Sep 30, 2023 3.08 Mn
Jun 30, 2023 2.95 Mn
Mar 31, 2023 2.73 Mn
Dec 31, 2022 537,376.00
Sep 30, 2022 355,762.00
Jun 30, 2022 320,323.00
Mar 31, 2022 76,942.00
Dec 31, 2021 25,680.00
Sep 30, 2021 53,525.00
Jun 30, 2021 38,998.00